The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
pH‐Dependent Anticancer Drug Release from Silk Nanoparticles
Open accessAbstract
Silk has traditionally been used as a suture material because of its excellent mechanical properties and biocompatibility. These properties have led to the development of different silk‐based material formats for tissue engineering and regenerative medicine. Although there have been a small number of studies about the use of silk particles for drug delivery, none of these studies have assessed the potential of silk to act as a stimulus‐responsive anticancer nanomedicine. This report demonstrates that an acetone precipitation of silk allows the formation of uniform silk nanoparticles (98 nm diameter, polydispersity index 0.109), with an overall negative surface charge (–33.6 ± 5.8 mV), in a single step. Silk nanoparticles are readily loaded with doxorubicin (40 ng doxorubicin/μg silk) and show pH‐dependent release (pH 4.5≫ 6.0 > 7.4). In vitro studies with human breast cancer cell lines demonstrates that the silk nanoparticles are not cytotoxic (IC 50 > 120 μg mL−1) and that doxorubicin‐loaded silk nanoparticles are able to overcome drug resistance mechanisms. Live cell fluorescence microscopy studies show endocytic uptake and lysosomal accumulation of silk nanoparticles. In summary, the pH‐dependent drug release and lysosomal accumulation of silk nanoparticles demonstrate the ability of drug‐loaded silk nanoparticles to serve as a lysosomotropic anticancer nanomedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Anumolu, R., Gustafson, J. A., Magda, J. J., Cappello, J., Ghandehari, H., & Pease, L. F. (2011) · ACS Nano · doi:10.1021/nn103585f · Cited by 56
RetractedMatsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
De Duve, C., De Barsy, T., Poole, B., Trouet, A., Tulkens, P., & Van Hoof, F. (1974) · Biochemical Pharmacology · doi:10.1016/0006-2952(74)90174-9 · Cited by 1,901
New Opportunities for an Ancient Material
Omenetto, F. G., & Kaplan, D. L. (2010) · Science · doi:10.1126/science.1188936 · Cited by 1,457
Self-citationMalafaya, P. B., Silva, G. A., & Reis, R. L. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.012 · Cited by 1,401
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Regulation of Silk Material Structure by Temperature-Controlled Water Vapor Annealing
Hu, X., Shmelev, K., Sun, L., Gil, E.-S., Park, S.-H., Cebe, P., & Kaplan, D. L. (2011) · Biomacromolecules · doi:10.1021/bm200062a · Cited by 649
Self-citationControlling silk fibroin particle features for drug delivery
Lammel, A. S., Hu, X., Park, S.-H., Kaplan, D. L., & Scheibel, T. R. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.024 · Cited by 538
Self-citationSilk nanospheres and microspheres from silk/pva blend films for drug delivery
Wang, X., Yucel, T., Lu, Q., Hu, X., & Kaplan, D. L. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.002 · Cited by 434
Self-citationEffect of processing on silk‐based biomaterials: Reproducibility and biocompatibility
Wray, L. S., Hu, X., Gallego, J., Georgakoudi, I., Omenetto, F. G., Schmidt, D., & Kaplan, D. L. (2011) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.31875 · Cited by 360
Self-citationSilk fibroin nanoparticles for cellular uptake and control release
Kundu, J., Chung, Y.-I., Kim, Y. H., Tae, G., & Kundu, S. C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.12.052 · Cited by 336
Duncan, R., & Richardson, S. C. W. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300293n · Cited by 332
Biodegradable block copolymers
Kumar, N., Ravikumar, M. N. V., & Domb, A. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00219-8 · Cited by 301
Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy
Gupta, V. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s5581 · Cited by 282
Bendele, A. M., Seely, J., Richey, C., Sennello, G., & Shopp, G. M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2396 · Cited by 279
Intracellular pH and the control of multidrug resistance.
Simon, S., Roy, D., & Schindler, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.3.1128 · Cited by 276
Silk fibroin spheres as a platform for controlled drug delivery
Wenk, E., Wandrey, A. J., Merkle, H. P., & Meinel, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.005 · Cited by 271
Formation of silk fibroin nanoparticles in water-miscible organic solvent and their characterization
Zhang, Y.-Q., Shen, W.-D., Xiang, R.-L., Zhuge, L.-J., Gao, W.-J., & Wang, W.-B. (2007) · Journal of Nanoparticle Research · doi:10.1007/s11051-006-9162-x · Cited by 261
Recombinant spider silk particles as drug delivery vehicles
Lammel, A., Schwab, M., Hofer, M., Winter, G., & Scheibel, T. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.060 · Cited by 161
Core‐Template‐Free Strategy for Preparing Hollow Nanospheres
Hu, Y., Jiang, X., Ding, Y., Chen, Q., & Yang, C. Z. (2004) · Advanced Materials · doi:10.1002/adma.200306579 · Cited by 157
Self‐Assembling Doxorubicin Silk Hydrogels for the Focal Treatment of Primary Breast Cancer
Seib, F. P., Pritchard, E. M., & Kaplan, D. L. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201201238 · Cited by 153
Self-citationBioengineered silk protein-based gene delivery systems
Numata, K., Subramanian, B., Currie, H. A., & Kaplan, D. L. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.028 · Cited by 138
Self-citationEngineered Microcapsules Fabricated from Reconstituted Spider Silk
Hermanson, K. D., Huemmerich, D., Scheibel, T., & Bausch, A. R. (2007) · Advanced Materials · doi:10.1002/adma.200602709 · Cited by 129
Seib, F. P., & Kaplan, D. L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.004 · Cited by 120
Self-citationImpact of processing parameters on the haemocompatibility of Bombyx mori silk films
Seib, F. P., Maitz, M. F., Hu, X., Werner, C., & Kaplan, D. L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.063 · Cited by 83
Self-citationProof of concept for next-generation nanoparticle drugs in humans
Sheridan, C. (2012) · Nature Biotechnology · doi:10.1038/nbt0612-471 · Cited by 69
Giannotti, M. I., Esteban, O., Oliva, M., Parajo, M. F. G., & Sanz, F. (2011) · Biomacromolecules · doi:10.1021/bm2003384 · Cited by 67
In vitro and in vivo Antitumor Activity of Doxorubicin‐Loaded Alginic‐Acid‐Based Nanoparticles
Cheng, Y., Yu, S., Wang, J., Qian, H., Wu, W., & Jiang, X. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200165 · Cited by 21
Cited by
Current development of biodegradable polymeric materials for biomedical applications
Song, R., Murphy, M., Li, C., Ting, K., Soo, C., & Zheng, Z. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s165440 · Cited by 915
The Biomedical Use of Silk: Past, Present, Future
Holland, C., Numata, K., Rnjak‐Kovacina, J., & Seib, F. P. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201800465 · Cited by 815
Self-citationChemical Basis of Interactions Between Engineered Nanoparticles and Biological Systems
Mu, Q., Jiang, G., Chen, L., Zhou, H., Fourches, D., Tropsha, A., & Yan, B. (2014) · Chemical Reviews · doi:10.1021/cr400295a · Cited by 679
Silk fibroin nanoparticle as a novel drug delivery system
Mottaghitalab, F., Farokhi, M., Shokrgozar, M. A., Atyabi, F., & Hosseinkhani, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.020 · Cited by 444
Silk Fibroin-Based Nanoparticles for Drug Delivery
Zhao, Z., Li, Y., & Xie, M.-B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16034880 · Cited by 332
Metadata
- Authors
- Seib, F. P., Jones, G. T., Rnjak‐Kovacina, J., Lin, Y., & Kaplan, D. L.
- Venue
- Advanced Healthcare Materials
- Publisher
- Wiley
- Published
- 2013-04-26
- Volume
- 2
- Issue
- 12
- Pages
- 1606-1611
- ISSN
- 2192-2640 (ISSN-L)
- 2192-2659
- OpenAlex
- W2077094286
- Cited by
- 260
- References
- 31
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.